Meta Pharmaceutical Services, a Blue Bell, PA-based provider of database management, statistical sales analytics and direct marketing services to pharmaceutical companies, has received $6m in subordinated debt from Praesidian Capital, a provider of mezzanine capital for small and mid-sized companies.
The investment supports the recapitalization of the company by DFW Capital Partners and management.
Meta Pharmaceutical Services is engaged in three service lines:
– Data Reporting and Management,
– Direct Mail and Fulfillment,
– Custom Programs.
Commenting on the investment, Tom Lawrence CEO of the company said: “With the financial support of Praesidian Capital and DFW Capital Partners, we are confident we will continue to attract new clients and additional engagements by developing and introducing new and innovative products and services”.
Meta was established in 2000 by the current management team.